GT Medical Technologies
Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors
$100MSeries E
Role not disclosedActivity from announced rounds
Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors
Adcendo develops antibody-drug conjugates that deliver cancer drugs to tumor-associated targets, with clinical programs in solid tumors and soft tissue sarcoma.
Develops thrombectomy systems for venous thromboembolism treatment
Provides digital treatments for insomnia, anxiety, and depression